Antimicrob Agents Chemother. 2016 May 9. pii: AAC.00627-16. [Epub ahead of print]
Lefamulin was evaluated against various S. pneumoniae serotypes collected from adults with lower respiratory tract infections. Lefamulin exhibited MIC50/90 of 0.12 and 0.25 μg/ml, respectively, against the entire collection (n=822). Similar results were obtained for lefamulin against each of most common serotypes, as well as multi-drug resistant isolates and strains non-susceptible to ceftriaxone or erythromycin. These data support the clinical development of lefamulin for the treatment of community-acquired respiratory tract infections.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
PMID: 27161634 [PubMed - as supplied by publisher]